| dc.date.accessioned | 2022-06-25T20:36:43Z | |
| dc.date.available | 2022-06-25T20:36:43Z | |
| dc.date.created | 2022-06-25T20:36:43Z | |
| dc.date.issued | 2022 | |
| dc.identifier | https://hdl.handle.net/20.500.12866/11888 | |
| dc.identifier | https://doi.org/10.1097/CCM.0000000000005407 | |
| dc.description.abstract | We enthusiastically read the commentary by Lapham related to our article, recently published in Critical Care Medicine, and would like to discuss the questions raised. Lapham points out the role of dietary sodium restriction (i.e., daily dietary intake of 120 mmol sodium in the hypertonic saline solution groups and 80 mmol sodium in the control groups) in three studies that used simultaneous use of hypertonic saline and diuretic (3-5)... | |
| dc.language | eng | |
| dc.publisher | Wolters Kluwer Health | |
| dc.relation | Critical Care Medicine | |
| dc.relation | 1530-0293 | |
| dc.rights | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
| dc.rights | info:eu-repo/semantics/restrictedAccess | |
| dc.subject | Letter | |
| dc.subject | replay | |
| dc.subject | dietary sodium restriction | |
| dc.title | Mischaracterizing the Data Regarding Hypertonic Saline Reply | |
| dc.type | info:eu-repo/semantics/article | |
